Prevalence of BRCA1 and BRCA2 Mutations in Women Diagnosed With Ductal Carcinoma in Situ

JAMA - Journal of the American Medical Association - United States
doi 10.1001/jama.293.8.964
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Medical Association (AMA)

Related search

Frequency of Pathogenic Germline Variants in BRCA1, BRCA2, PALB2, CHEK2 and TP53 in Ductal Carcinoma in Situ Diagnosed in Women Under the Age of 50 Years

Breast Cancer Research
Cancer ResearchOncology
2019English

Physical Activity Behaviors in Women With Newly Diagnosed Ductal Carcinoma-In-Situ

Annals of Surgical Oncology
OncologySurgery
2009English

Prevalence and Characteristics of Pancreatic Cancer in Families With BRCA1 and BRCA2 Mutations

Familial Cancer
Cancer ResearchOncologyGenetics
2008English

Trends in Treatment Patterns and Clinical Outcomes in Young Women Diagnosed With Ductal Carcinoma in Situ

Clinical Breast Cancer
Cancer ResearchOncology
2018English

Endocrine Therapy Initiation and Medical Oncologist Utilization Among Women Diagnosed With Ductal Carcinoma in Situ

Oncologist
Cancer ResearchMedicineOncology
2017English

Prevalence of BRCA1 and BRCA2 Mutations in Breast Cancer Patients From Brazil

Breast Cancer Research and Treatment
Cancer ResearchOncology
2006English

Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer

JAMA - Journal of the American Medical Association
Medicine
2012English

Mutations in BRCA1, BRCA2, and PALB2, and a Panel of 50 Cancer-Associated Genes in Pancreatic Ductal Adenocarcinoma

Scientific Reports
Multidisciplinary
2018English

Breast Cancer in Young Women: Prevalence of LOH at P53, BRCA1 and BRCA2

Breast Cancer Research
Cancer ResearchOncology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy